European Journal of Epidemiology

, Volume 27, Issue 12, pp 933–943 | Cite as

Combined effect of lung function level and decline increases morbidity and mortality risks

  • Penelope Baughman
  • Jacob L. Marott
  • Peter Lange
  • Christopher J. Martin
  • Anoop Shankar
  • Edward L. Petsonk
  • Eva Hnizdo
RESPIRATORY EPIDEMIOLOGY

Abstract

Lung function level and decline are each predictive of morbidity and mortality. Evaluation of the combined effect of these measurements may help further identify high-risk groups. Using Copenhagen City Heart Study longitudinal spirometry data (n = 10,457), 16–21 year risks of chronic obstructive pulmonary disease (COPD) morbidity, COPD or coronary heart disease mortality, and all-cause mortality were estimated from combined effects of level and decline in forced expiratory volume in one second (FEV1). Risks were evaluated using Cox proportional hazards models for individuals grouped by combinations of baseline predicted FEV1 and quartiles of slope. Hazard ratios (HR) and 95 % confidence intervals (CI) were estimated using stratified analysis by gender, smoking status, and baseline age (≤45 and >45). For COPD morbidity, quartiles of increasing FEV1 decline increased HRs (95 % CI) for individuals with FEV1 at or above the lower limit of normal (LLN) but below 100 % predicted, reaching 5.11 (2.58–10.13) for males, 11.63 (4.75–28.46) for females, and 3.09 (0.88–10.86) for never smokers in the quartile of steepest decline. Significant increasing trends were also observed for mortality and in individuals with a baseline age ≤45. Groups with ‘normal’ lung function (FEV1 at or above the LLN) but excessive declines (fourth quartile of FEV1 slope) had significantly increased mortality risks, including never smokers and individuals with a baseline age ≤45.

Keywords

Chronic obstructive pulmonary disease Morbidity Mortality Respiratory symptoms Spirometry 

References

  1. 1.
    Beaty TH, Cohen BH, Newill CA, Menkes HA, Diamond EL, Chen CJ. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol. 1982;116:102–13.PubMedGoogle Scholar
  2. 2.
    Beaty TH, Newill CA, Cohen BH, Tockman MS, Bryant SH, Spurgeon HA. Effects of pulmonary function on mortality. J Chronic Dis. 1985;38:703–10.PubMedCrossRefGoogle Scholar
  3. 3.
    Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134:1011–9.PubMedGoogle Scholar
  4. 4.
    Persson C, Bengtsson C, Lapidus L, Rybo E, Thiringer G, Wedel H. Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol. 1986;124:942–8.PubMedGoogle Scholar
  5. 5.
    Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J. 1991;4:1080–7.PubMedGoogle Scholar
  6. 6.
    Bang KM, Gergen PJ, Kramer R, Cohen B. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest. 1993;103:536–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Rodriguez BL, Masaki K, Burchfiel C, et al. Pulmonary function decline and 17-year total mortality: the Honolulu heart program. Am J Epidemiol. 1994;140:398–408.PubMedGoogle Scholar
  8. 8.
    Tockman MS, Pearson JD, Fleg JL, et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med. 1995;151:390–8.PubMedGoogle Scholar
  9. 9.
    Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996;313:711–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Neas LM, Schwartz J. Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol. 1998;147:1011–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Ryan G, Knuiman MW, Divitini ML, James A, Musk AW, Bartholomew HC. Decline in lung function and mortality: the Busselton health study. J Epidemiol Community Health. 1999;53:230–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo health study. Chest. 2000;118:656–64.PubMedCrossRefGoogle Scholar
  13. 13.
    Beeckman LA, Wang ML, Petsonk EL, Wagner GR. Rapid declines in FEV1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States. Am J Respir Crit Care Med. 2001;163:633–9.PubMedGoogle Scholar
  14. 14.
    Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries study. Thorax. 2001;56:703–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the first national health and nutrition examination survey follow up study. Thorax. 2003;58:388–93.PubMedCrossRefGoogle Scholar
  16. 16.
    Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med. 2006;173:985–90.PubMedCrossRefGoogle Scholar
  18. 18.
    Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax. 2006;61:472–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Lash TL, Johansen MB, Christensen S, et al. Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung. 2011;189:27–35.PubMedCrossRefGoogle Scholar
  20. 20.
    American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD, version 1.2. 2004. www.thoracic.org/go/copd. Accessed 17 Feb 2011.
  21. 21.
    Hogg JC, Pierce RA. Remodelling of peripheral lung tissue in COPD. Eur Respir J. 2008;31:913–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Allen TC. Pathology of small airways disease. Arch Pathol Lab Med. 2010;134:702–18.PubMedGoogle Scholar
  23. 23.
    Cornwell WD, Kim V, Song C, Rogers TJ. Pathogenesis of inflammation and repair in advanced COPD. Semin Respir Crit Care Med. 2010;31:257–66.PubMedCrossRefGoogle Scholar
  24. 24.
    Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Akkermans RP, Berrevoets MA, Smeele IJ, et al. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med. 2012;12:12.PubMedCrossRefGoogle Scholar
  26. 26.
    Hankinson JL, Wagner GR. Medical screening using periodic spirometry for detection of chronic lung disease. Occup Med. 1993;8:353–61.PubMedGoogle Scholar
  27. 27.
    Townsend MC. Spirometry in the occupational health setting–2011 update. J Occup Environ Med. 2011;53:569–84.PubMedCrossRefGoogle Scholar
  28. 28.
    Townsend MC. Evaluating pulmonary function change over time in the occupational setting. J Occup Environ Med. 2005;47:1307–16.PubMedCrossRefGoogle Scholar
  29. 29.
    Lange P. Spirometric findings as predictors of survival. Thorax. 2011;66:1–2.PubMedCrossRefGoogle Scholar
  30. 30.
    Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40.PubMedGoogle Scholar
  31. 31.
    Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study. Eur Heart J. 2001;3:H1–83.CrossRefGoogle Scholar
  32. 32.
    Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ. 1968;56:1–188.PubMedGoogle Scholar
  33. 33.
    Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263–8.PubMedGoogle Scholar
  34. 34.
    Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Lange P, Mogelvang R, Marott JL, Vestbo J, Jensen JS. Cardiovascular morbidity in COPD: a study of the general population. COPD. 2010;7:5–10.PubMedCrossRefGoogle Scholar
  36. 36.
    Burrows B, Lebowitz MD, Camilli AE, Knudson RJ. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis. 1986;133:974–80.PubMedGoogle Scholar
  37. 37.
    Miller MR, Pedersen OF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J. 2010;35:873–82.PubMedCrossRefGoogle Scholar
  38. 38.
    Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117:1146–61.PubMedCrossRefGoogle Scholar
  39. 39.
    Doherty DE. A review of the role of FEV1 in the COPD paradigm. COPD. 2008;5:310–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9:531–41.PubMedGoogle Scholar
  41. 41.
    Baughman P, Marott JL, Lange P, Andrew M, Hnizdo E. Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort. COPD. 2011;8:103–13.PubMedCrossRefGoogle Scholar
  42. 42.
    Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61:935–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Camp PG, O’Donnell DE, Postma DS. Chronic obstructive pulmonary disease in men and women: myths and reality. Proc Am Thorac Soc. 2009;6:535–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180:3–10.PubMedCrossRefGoogle Scholar
  45. 45.
    Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J. 2006;28:781–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Sin DD. Is COPD really a cardiovascular disease? Chest. 2009;136:2.CrossRefGoogle Scholar
  47. 47.
    Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25:253–60.PubMedCrossRefGoogle Scholar
  48. 48.
    Hnizdo E, Sircar K, Glindmeyer HW, Petsonk EL. Longitudinal limits of normal decline in lung function in an individual. J Occup Environ Med. 2006;48:625–34.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht (outside the USA) 2012

Authors and Affiliations

  • Penelope Baughman
    • 1
  • Jacob L. Marott
    • 2
  • Peter Lange
    • 3
  • Christopher J. Martin
    • 4
  • Anoop Shankar
    • 5
  • Edward L. Petsonk
    • 6
  • Eva Hnizdo
    • 7
  1. 1.Division of Respiratory Disease Studies, Surveillance BranchNational Institute for Occupational Safety and HealthMorgantownUSA
  2. 2.Bispebjerg University HospitalCopenhagenDenmark
  3. 3.Department of Public Health, Section of Social MedicineCopenhagen UniversityCopenhagenDenmark
  4. 4.Department of Community Medicine, Institute of Occupational and Environmental HealthWest Virginia UniversityMorgantownUSA
  5. 5.Department of Community MedicineWest Virginia UniversityMorgantownUSA
  6. 6.Department of Medicine, Pulmonary and Critical Care MedicineWest Virginia UniversityMorgantownUSA
  7. 7.Division of Respiratory Disease Studies, Surveillance BranchNational Institute for Occupational Safety and HealthMorgantownUSA

Personalised recommendations